Fennec Pharmaceuticals (FENC) Short Interest Ratio & Short Volume → AI Cracks Open Largest Untapped Energy Reserve on Earth (From Banyan Hill Publishing) (Ad) Free FENC Stock Alerts $11.07 +1.13 (+11.37%) (As of 03/18/2024 ET) Add Compare Share Share Short InterestStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial MediaStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSocial Media Fennec Pharmaceuticals Short Interest DataCurrent Short Volume1,710,000 sharesPrevious Short Volume1,750,000 sharesChange Vs. Previous Month-2.29%Dollar Volume Sold Short$16.19 millionShort Interest Ratio / Days to Cover13.9Last Record DateFebruary 29, 2024Outstanding Shares27,040,000 sharesFloat Size19,890,000 sharesShort Percent of Float8.60%Today's Trading Volume447,137 sharesAverage Trading Volume96,275 sharesToday's Volume Vs. Average464% Short Selling Fennec Pharmaceuticals ? Sign up to receive the latest short interest report for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort InterestDays to CoverShort Percent of FloatFENC Short Interest Over TimeFENC Days to Cover Over TimeFENC Percentage of Float Shorted Over Time Ad Weiss RatingsThe ONE AI sSock to own now. (It’s not Nvidia.)Don’t panic — you haven’t missed the boat on AI. In fact, it has barely launched. Sure, the early stages of this boom were big … But I believe the real wealth in AI has yet to be made …Click here to see the presentation now. Fennec Pharmaceuticals Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 2/29/20241,710,000 shares $16.19 million -2.3%8.6%13.9 $9.47 2/15/20241,750,000 shares $16.00 million -2.2%8.9%14.8 $9.14 1/31/20241,790,000 shares $17.88 million -3.8%9.1%15.3 $9.99 1/15/20241,860,000 shares $19.14 million -7.5%9.5%15.3 $10.29 12/31/20232,010,000 shares $22.55 million -1.5%9.2%15.6 $11.22 12/15/20232,040,000 shares $20.30 million +6.8%9.4%15 $9.95 Get the Latest News and Ratings for FENC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Fennec Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 11/30/20231,910,000 shares $16.43 million -2.6%8.8%19.1 $8.60 11/15/20231,960,000 shares $15.70 million +2.1%9.0%20.9 $8.01 10/31/20231,920,000 shares $13.21 million -0.5%8.7%23 $6.88 10/15/20231,930,000 shares $13.32 million +19.1%8.8%25.4 $6.90 9/30/20231,620,000 shares $12.17 million +1.3%7.4%22.7 $7.51 9/15/20231,600,000 shares $12.69 million -3.0%7.3%27.3 $7.93 8/31/20231,650,000 shares $13.46 million -0.6%7.5%15.2 $8.16 8/15/20231,660,000 shares $13.76 million +0.6%7.6%14.5 $8.29 7/31/20231,650,000 shares $14.70 million -2.9%7.5%13.3 $8.91 7/15/20231,700,000 shares $14.93 million -1.2%7.8%13.8 $8.78 6/30/20231,720,000 shares $15.19 million -1.2%7.9%13.6 $8.83 6/15/20231,740,000 shares $16.84 million +1.2%8.0%12.6 $9.68 5/31/20231,720,000 shares $13.04 million +17.0%7.9%19.1 $7.58 5/15/20231,470,000 shares $11.23 million No Change6.7%17 $7.64 10/31/2022547,400 shares $4.82 million +17.4%2.9%3.6 $8.80 10/15/2022466,300 shares $3.67 million -6.3%2.4%3.3 $7.87 9/30/2022497,800 shares $4.03 million +1.1%2.6%3.9 $8.10 9/15/2022492,200 shares $3.31 million +39.7%2.6%4.3 $6.72 8/31/2022352,300 shares $2.47 million +16.2%1.6%7.1 $7.00 8/15/2022303,100 shares $2.06 million +64.7%1.4%8 $6.79 7/31/2022184,000 shares $1.23 million +18.3%0.9%6.3 $6.68 7/15/2022155,500 shares $1.04 million -1.3%0.7%5.3 $6.72 6/30/2022157,600 shares $879,408.00 -25.5%1.0%5.5 $5.58 6/15/2022211,400 shares $1.19 million -18.0%1.3%7.2 $5.61 5/31/2022257,900 shares $1.47 million -2.7%1.2%8 $5.71 5/15/2022265,100 shares $1.46 million -0.1%1.2%7.5 $5.52 4/30/2022265,300 shares $1.53 million -1.7%1.2%7.2 $5.78 4/15/2022269,800 shares $1.67 million -0.4%1.3%6.8 $6.20 3/31/2022270,800 shares $1.52 million -3.3%N/A5.9 $5.60 3/15/2022279,900 shares $1.46 million -0.7%1.3%4.8 $5.20 2/28/2022281,800 shares $1.58 million -5.8%1.3%4.1 $5.59 2/15/2022299,200 shares $1.45 million +2.6%1.4%2.1 $4.86 1/31/2022291,500 shares $1.36 million -7.5%1.4%1.9 $4.65 1/15/2022315,100 shares $1.46 million +4.0%N/A0 $4.63The only AI company you should be looking at (Ad)This is the ONLY AI company you should be watching right now. No. It's not Nvidia, Intel, or Microsoft... It's a tiny biotech using proprietary AI to assist in new drug discovery at a rate 100,000 times faster than a human. This new drug discovery technique will change the market. And that's why they received a $50 million investment from an AI powerhouse.Get the stock ticker here >>> FENC Short Interest - Frequently Asked Questions What is Fennec Pharmaceuticals' current short interest? Short interest is the volume of Fennec Pharmaceuticals shares that have been sold short but have not yet been closed out or covered. As of February 29th, investors have sold 1,710,000 shares of FENC short. 8.60% of Fennec Pharmaceuticals' shares are currently sold short. Learn More on Fennec Pharmaceuticals' current short interest. What is a good short interest ratio for Fennec Pharmaceuticals? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. FENC shares currently have a short interest ratio of 14.0. Learn More on Fennec Pharmaceuticals's short interest ratio. Which institutional investors are shorting Fennec Pharmaceuticals? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Fennec Pharmaceuticals: Citadel Advisors LLC, and Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Fennec Pharmaceuticals? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 8.60% of Fennec Pharmaceuticals' floating shares are currently sold short. Is Fennec Pharmaceuticals' short interest increasing or decreasing? Fennec Pharmaceuticals saw a decline in short interest during the month of February. As of February 29th, there was short interest totaling 1,710,000 shares, a decline of 2.3% from the previous total of 1,750,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. What is Fennec Pharmaceuticals' float size? Fennec Pharmaceuticals currently has issued a total of 27,040,000 shares. Some of Fennec Pharmaceuticals' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Fennec Pharmaceuticals currently has a public float of 19,890,000 shares. How does Fennec Pharmaceuticals' short interest compare to its competitors? 8.60% of Fennec Pharmaceuticals' shares are currently sold short. Here is how the short interest of companies in the industry of "biological products, except diagnostic" compare to Fennec Pharmaceuticals: Compass Therapeutics, Inc. (2.42%), Agenus Inc. (11.32%), Sutro Biopharma, Inc. (3.95%), Mesoblast Limited (0.50%), Ocugen, Inc. (14.29%), Coherus BioSciences, Inc. (21.73%), Gritstone bio, Inc. (9.19%), Compugen Ltd. (2.11%), Century Therapeutics, Inc. (8.71%), Acumen Pharmaceuticals, Inc. (1.86%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($4.39 billion), General Motors ($3.88 billion), Super Micro Computer, Inc. ($3.51 billion), Charter Communications, Inc. ($3.22 billion), Occidental Petroleum Co. ($3.13 billion), Tractor Supply ($2.76 billion), Coinbase Global, Inc. ($2.63 billion), Suncor Energy Inc. ($2.48 billion), Moderna, Inc. ($2.04 billion), and Royal Caribbean Cruises Ltd. ($1.87 billion). View all of the most shorted stocks. What does it mean to sell short Fennec Pharmaceuticals stock? Short selling FENC is an investing strategy that aims to generate trading profit from Fennec Pharmaceuticals as its price is falling. FENC shares are trading up $1.13 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Fennec Pharmaceuticals? A short squeeze for Fennec Pharmaceuticals occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of FENC, which in turn drives the price of the stock up even further. How often is Fennec Pharmaceuticals' short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including FENC, twice per month. The most recent reporting period available is February, 29 2024. More Short Interest Resources from MarketBeat Related Companies: Compass Therapeutics Short Interest Agenus Short Interest Sutro Biopharma Short Interest Mesoblast Short Interest Ocugen Short Interest Coherus BioSciences Short Interest Gritstone bio Short Interest Compugen Short Interest Century Therapeutics Short Interest Acumen Pharmaceuticals Short Interest Short Interest Tools: Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NASDAQ:FENC) was last updated on 3/19/2024 by MarketBeat.com Staff From Our PartnersCentral Bank Gold Heist In ProgressColonial Metals8,788% Return Predicted For THIS Crypto (already up 40% in 6 months)Paradigm PressLike Tiny Crypto Retirement FundsCrypto 101 MediaMake This $3 Trade the Instant the Opening Bell RingsMonument Traders AllianceStock-Picking AI Predicts #1 Stock of 2024AltimetrySHOCKING Footage From Tesla Gigafactory In Austin, TexasInvestorPlaceThis AI Trade Machine Made 1,729%* (With 89% Wins)Prosper Trading AcademyThe world’s greatest investmentPorter & Company